Novartis has discontinued two undisclosed programs under its current partership with Voyager, the biotech announced last ...
The Greater Philadelphia life sciences ecosystem has over 1,200 life sciences establishments, including 450 biotech research ...
Clarity on employment terms is essential to protect careers. In this column, Kaye/Bassman’s Michael Pietrack speaks to ...
Despite falling short of its primary Phase II objective, Nektar plans to push its T cell stimulator rezpeg into Phase III ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results